nonessential amino acids, vitamins, antibiotics, and 5 x 10 5 M mercaptoethanol as described earlier (8) . For plaque-forming cell (PFC) responses, two kinds of antigenic challenge were used. "T-independent" responses were elicited with trinitrophenylated aminoheptyl ficoll (TNP-ficoll); "T-dependent" responses were induced with trmitrophenylated red blood cells (see Results). In the latter case, donor mice were primed 4 days before culture with 1-4 x 10 ~ red blood cells as described by Kettman and Dutton (9) .
Assays for Immune Responses. Plaque-forming cell responses of individual triplicate cultures to TNP-goat RBC (TNP-GRBC), GRBC, or donkey RBC were performed on day 3-4 either by the Cunningham slide technique (10) or a modified Jerne plate method. Determination of killer cell activity was done on day 5 as described earlier (8, 11) using 51chromium-labeled TNP-clone 1D (CL1D) (Ho2 k L-cell derivative) or ~Cr-CL1D as targets.
Results

Inhibition of the Antibody Response by Haptenated Spleen Cells.
Previous studies in our laboratory had shown that pretreatment of rats with syngeneic TNP-spleen cells intravenously (i.v.) dramatically reduced the ability of these animals to respond to TNP-protein challenge in adjuvant as measured by direct and indirect PFC (5). 1 Since Shearer and co-workers have found that TNPsyngeneic SC stimulate the generation of cytotoxic T cells in vitro (7) , it was important to determine in the same system whether these differences represented differential recognition of the same conjugate by B-and T-cell subpopulations. To test this, 107 spleen cells from C3H/St mice were cultured alone or with 106 irradiated TNP-SC _+ various doses of TNP-ficoll. The results (Table I) showed that the presence of TNP-SC totally blocked the in vitro responses of normal C3H SC to TNP-ficoll at doses up to 10 ng; the response to 100 ng TNPficoll was inhibited to less than 20% of the response of control cultures. No effect on the response to GRBC was observed, indicating a specific inhibition of the anti-TNP response. Additional experiments have demonstrated that TNP-SC do not inhibit the response to non-cross-reactive (8) fluorescein-ficoll either in vitro or in vivo, while the response to TNP-ficoll is consistently reduced by such treatment (data not shown).
To further document the suppression by haptenated spleen cells, we have examined the effect of TNP-SC on the in vitro response to TNP-RBC, a highly Tcell-dependent response (9) . As shown in Table II , the presence of 106 TNP-SC inhibited the anti-TNP PFC response in RBC-primed spleen cells more than 75%; again, no significant effect of TNP-SC was seen on the anti-RBC response.
Stimulation of Cytotoxic T Cells and Inhibition of B-Cell Responses by TNPSpleen Cells. Since the cultivation of normal spleen cells with TNP-SC stimu-
lates the generation of cytotoxic T cells specific for hapten-modified H-2 determinants (7, 12), we next examined whether TNP-SC could simultaneously inhibit the PFC response of normal SC, while stimulating a "TNP-specific" cytotoxic Tcell response. The results in Table III indicate that this is indeed the case. C3H/ St spleen cells cultured with TNP-ficoll (group D) respond well in terms of PFC, but yield no significant killer cell activity. The presence of 106 TNP-SC totally blocks the PFC responsiveness of C3H spleen cells (group C) while stimulating a good cytotoxic response in the 51Cr release assay. As also observed by Shearer (personal communication), TNP-SC do not stimulate a significant PFC response alone, but consistently induce TNP-specific killers (group B).
Finally, to determine the minimum number of TNP-SC necessary to both (Table IV) showed that as few as l0 s TNP-SC could specifically inhibit the PFC response by 80% while simultaneously inducing a maximal killer cell response. Interestingly, the decrease in suppression and killer cell induction occurred at the same dose of TNP-SC.
Discussion
The induction of tolerance with haptenated nonimmunogenic carriers is well established. Haptens coupled to isologous serum proteins, especially IgG (2), or haptenated lymphoid or red cells are effective tolerogens as measured by the humoral immune response (1-3, 13) 1 and contact hypersensitivity (CH) (3, 4) . 1 Thus isologous carriers can effect both B-and T-cell tolerance. These carriers SCOTT AND LONG BRIEF DEFINITIVE REPORT may function as tolerogens for several reasons: their persistence in the circulation or at the cell surface (14), their favorable "homing" patterns to B-or T-cell areas (15) , associative recognition (e.g., IgG by Fc receptors), or finally by the activation of suppressor cells to autologous antigens (16) . At present, it is difficult to distinguish among these mechanisms; moreover, they may not be mutually exclusive. In contrast to these in vivo tolerance observations, the cultivation of normal spleen cells with haptenated syngeneic cells in vitro results in the generation of cytotoxic T cells specific for hapten-modified histocompatibility antigens (7, see reference 12). Therefore, haptenated syngeneic cells are tolerogenic for humoral and CH responses in vivo, but are immunogenic for a cytotoxic T-cell response in vitro. In addition, Naor et al. have found that haptenated spleen cells (prepared after affinity labeling) would block PFC induction in vitro (17) . In the present report, we have examined the PFC and killer cell responses in the same culture of normal spleen cells in the presence or absence of haptenated spleen cells. We have found that the same preparation of TNP-spleen cells will block a PFC response while simultaneously stimulating a cytotoxic T-cell response in vitro. The inhibition of the PFC response is probably not due to the presence of free hapten since monovalent hapten does not inhibit PFC responses except at very high levels. Moreover, titration of TNP-SC in vivo 1 or in vitro (Table IV) indicated that these cells were far more tolerogenic than equivalent molar amounts of TNP-isologous Ig, for example (data not shown). While the mechanism of B-cell unresponsiveness in this system is unknown, it is clear that the results of an encounter with modified self in vitro can be clearly different for B cells and T (Ly 2,3) cells. Since the T cells involved in CH may also be rendered tolerant by the appropriate exposure to modified self (4), we must consider these Ly 1 (18) cells in any discussion of differential tolerance induction. One interpretation of the contrasting results is that there are different triggering signals or thresholds for each of these populations and what is immunogenic for one may be tolerogenic for another. Alternatively, both B and TcH cells have receptors for modified self but cannot be triggered (receptor blockade?) or are inhibited from responding by the simultaneous generation of cytotoxic (suppressor?) T cells. This is currently being tested.
Summary
Normal spleen cells cultured with TNP-modified syngeneic spleen cells fail to mount an anti-TNP PFC response to TNP-ficoll or TNP-red blood cells, but go on to generate cytotoxic T cells directed at hapten-modified H-2, These results suggest that hapten-modified spleen cells may differentially induce B-ceU tolerance and T-(Ly 2,3) cell immunity. The differential response to modified self by lymphocyte subpopulations is discussed.
